Drug Facts

Type of Drug:

Fertility drug.

How the Choriogonaootropin Alfa Works:

Choriogonadotropin alfa contains some of the same proteins that are in the naturally occurring hormones human chorionic gonadotropin (HCG), follicle stimulating hormone (FSH), and aluminizing hormone (LH).

Uses of Choriogonaootropin Alfa:

For use in women in assisted reproductive technology (ART) programs.

Choriogonadotropin alfa is given when monitoring indicates that the follicles have developed adequately. Choriogonadotropin alfa induces ovulation.

To bring about ovulation and pregnancy in infertile patients with irregular cycles.

Precautions:

Ovarian enlargement/hyperstimulation: Choriogonadotropin alfa may cause ovarian enlargement or ovarian hyperstimulation syndrome (OHSS). OHSS can develop rapidly (within 24 hours to several days) and can become a serious medical event. Contact your doctor immediately if you experience severe pelvic pain, nausea, vomiting, and weight gain.

Multiple births: Choriogonadotropin alfa treatment has been associated with multiple births. Consult your doctor.

Pregnancy: Do not use during pregnancy. The risk of use in a pregnant woman clearly outweighs any possible benefit.

Breastfeeding: It is not known if choriogonadotropin alfa appears in breast milk. Do not breastfeed while taking this medicine.

Children: Safety and effectiveness in children have not been established. Lab tests will be required to monitor therapy.

Drug Interactions:

Tell your doctor or pharmacist if you are taking or planning to take any over­the-counter or prescription medications or dietary supplements while taking choriogonadotropin alfa. Doses of one or both drugs may need to be modified or a different drug may need to be prescribed.

Side Effects of the Choriogonaootropin Alfa:

Every drug is capable of producing side effects. Many choriogonadotropin alfa users experience no, or minor, side effects. The frequency and severity of side effects depend on many factors including dose, duration of therapy, and individual susceptibility. Possible side effects include:

Digestive Tract: Stomach pain; nausea; vomiting.

Other: Injection site pain; bruising; post-operative pain.

Guidelines for Use:

• This medicine is injected subcutaneous (SC; under the skin). Use exactly as prescribed.
• Follow the injecting procedure taught to you by your health care provider.
• Visually inspect the solution. Do not use if discolored or contains particles.
• Overstimulation of the ovary may OCCur (ovarian hyper stimulation syndrome; OHSS). Contact your doctor immediately if you experience severe pelvic pain, nausea, vomiting, Or weight gain.
• Use immediately after reconstitution. Discard unused solution.
• Lab tests will be required to monitor therapy. Be sure to keep appointments.
• Store vials at controlled room temperature (68° to 77°F) or refrigerate (36° to 46°F). Protect from fight.

Tagged under:assisted reproductive technology, choriogonadotropin alfa, during pregnancy, Fertility Agents, follicle stimulating hormone, hormone lh ovarian hyperstimulation syndrome